• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双螺环色满酮类化合物作为结核分枝杆菌有效的抑制剂:合成与生物评价。

Bis-spirochromanones as potent inhibitors of Mycobacterium tuberculosis: synthesis and biological evaluation.

机构信息

Green and Medicinal Chemistry Lab, Department of Chemistry, Osmania University, Hyderabad, Telangana State, 500 007, India.

Molecular Modeling and Medicinal Chemistry group, Department of Chemistry, Osmania University, Hyderabad, Telangana State, 500 007, India.

出版信息

Mol Divers. 2017 Nov;21(4):999-1010. doi: 10.1007/s11030-017-9779-y. Epub 2017 Aug 24.

DOI:10.1007/s11030-017-9779-y
PMID:28840414
Abstract

On the basis of reported antimycobacterial property of chroman-4-one pharmacophore, a series of chemically modified bis-spirochromanones were synthesized starting from 2-hydroxyacetophenone and 1,4-dioxaspiro[4.5] decan-8-one using a Kabbe condensation approach. The synthesized bis-spirochromanones were established based on their spectral data and X-ray crystal structure of 6e. All synthesized compounds were evaluated against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain, finding that some products exhibited good antimycobacterial activity with minimum inhibitory concentration as low as [Formula: see text]. Docking studies were carried out to identify the binding interactions of compounds II, 6a and 6n with FtsZ. Compounds exhibiting good in vitro potency in the MTB MIC assay were further evaluated for toxicity using the HEK cell line.

摘要

基于色满-4-酮药效团的报道的抗分枝杆菌性质,我们从 2-羟基苯乙酮和 1,4-二氧杂螺[4.5]癸烷-8-酮开始,使用 Kabbe 缩合方法合成了一系列化学修饰的双螺[色满-4,3'-吡咯烷]。基于其光谱数据和 6e 的 X 射线晶体结构确定了合成的双螺[色满-4,3'-吡咯烷]。所有合成的化合物均针对结核分枝杆菌 H37Rv(ATCC 27294)菌株进行了评估,发现一些产物表现出良好的抗分枝杆菌活性,最低抑菌浓度低至[公式:见正文]。进行了对接研究以确定化合物 II、6a 和 6n 与 FtsZ 的结合相互作用。在 MTB MIC 测定中表现出良好的体外效力的化合物进一步使用 HEK 细胞系评估了毒性。

相似文献

1
Bis-spirochromanones as potent inhibitors of Mycobacterium tuberculosis: synthesis and biological evaluation.双螺环色满酮类化合物作为结核分枝杆菌有效的抑制剂:合成与生物评价。
Mol Divers. 2017 Nov;21(4):999-1010. doi: 10.1007/s11030-017-9779-y. Epub 2017 Aug 24.
2
Design, synthesis and docking studies of some novel (R)-2-(4'-chlorophenyl)-3-(4'-nitrophenyl)-1,2,3,5-tetrahydrobenzo[4,5] imidazo [1,2-c]pyrimidin-4-ol derivatives as antitubercular agents.设计、合成及对接研究新型(R)-2-(4'-氯苯基)-3-(4'-硝基苯基)-1,2,3,5-四氢苯并[4,5]咪唑并[1,2-c]嘧啶-4-醇衍生物作为抗结核药物。
Eur J Med Chem. 2014 Aug 18;83:245-55. doi: 10.1016/j.ejmech.2014.06.019. Epub 2014 Jun 11.
3
Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.新型吡唑啉类抗结核和细胞毒性药物的合成、生物学评价及分子对接研究
Infect Disord Drug Targets. 2019;19(3):310-321. doi: 10.2174/1871526519666181217120626.
4
Design and synthesis of 9H-fluorenone based 1,2,3-triazole analogues as Mycobacterium tuberculosis InhA inhibitors.基于 9H-芴酮的 1,2,3-三唑类似物的设计与合成作为结核分枝杆菌 InhA 抑制剂。
Chem Biol Drug Des. 2018 Jun;91(6):1078-1086. doi: 10.1111/cbdd.13127. Epub 2018 Mar 8.
5
Novel amide and sulphonamide derivatives of 6-(piperazin-1-yl)phenanthridine as potent Mycobacterium tuberculosis H37Rv inhibitors.6-(哌嗪-1-基)菲啶酰胺和磺酰胺衍生物作为新型结核分枝杆菌 H37Rv 抑制剂。
Eur J Med Chem. 2015 Mar 6;92:415-26. doi: 10.1016/j.ejmech.2015.01.013. Epub 2015 Jan 9.
6
Structural comparison of Mtb-DHFR and h-DHFR for design, synthesis and evaluation of selective non-pteridine analogues as antitubercular agents.结核分枝杆菌二氢叶酸还原酶(Mtb-DHFR)与人类二氢叶酸还原酶(h-DHFR)的结构比较,用于设计、合成和评估选择性非喋呤类似物作为抗结核药物。
Bioorg Chem. 2018 Oct;80:319-333. doi: 10.1016/j.bioorg.2018.04.022. Epub 2018 May 11.
7
In Silico and in Vitro Studies of Fluorinated Chroman-2-Carboxilic Acid Derivatives as an Anti-tubercular Agent.含氟苯并二氢吡喃-2-羧酸衍生物作为抗结核药物的计算机模拟和体外研究
Folia Med (Plovdiv). 2018 Dec 1;60(4):601-609. doi: 10.2478/folmed-2018-0034.
8
Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.鉴定一种新型异柠檬酸裂解酶抑制剂作为针对活性和非复制性结核分枝杆菌的强效抗结核药物。
Tuberculosis (Edinb). 2016 Mar;97:38-46. doi: 10.1016/j.tube.2015.12.003. Epub 2016 Jan 6.
9
Design, Synthesis, and in vitro antitubercular activity of 1,2,3-triazolyl-dihydroquinoline derivatives.设计、合成及 1,2,3-三唑基二氢喹啉衍生物的体外抗结核活性。
Chem Biol Drug Des. 2018 Jul;92(1):1315-1323. doi: 10.1111/cbdd.13196. Epub 2018 May 18.
10
Synthesis and antitubercular activity of amino alcohol fused spirochromone conjugates.氨基醇并色酮类化合物的合成及抗结核活性。
Bioorg Med Chem Lett. 2013 Mar 1;23(5):1416-9. doi: 10.1016/j.bmcl.2012.12.073. Epub 2013 Jan 5.

引用本文的文献

1
Spirocyclic compounds: potential drug leads in the fight against .螺环化合物:对抗……的潜在药物先导物
Future Med Chem. 2025 Apr;17(7):819-837. doi: 10.1080/17568919.2025.2479413. Epub 2025 Mar 19.
2
1,2,3-Triazole-fused spirochromenes as potential anti-tubercular agents: synthesis and biological evaluation.作为潜在抗结核药物的1,2,3-三唑稠合螺色烯:合成与生物学评价
RSC Adv. 2018 May 9;8(30):16997-17007. doi: 10.1039/c8ra03197e. eCollection 2018 May 3.
3
Chromanone-A Prerogative Therapeutic Scaffold: An Overview.色满酮 - A:一种具有优势的治疗性骨架:综述。

本文引用的文献

1
Maximum flow approach to prioritize potential drug targets of Mycobacterium tuberculosis H37Rv from protein-protein interaction network.基于蛋白质-蛋白质相互作用网络的最大流方法对结核分枝杆菌H37Rv潜在药物靶点进行优先级排序
Clin Transl Med. 2015 Dec;4(1):61. doi: 10.1186/s40169-015-0061-6. Epub 2015 Jun 5.
2
Synthesis, structure-activity relationship studies, and antibacterial evaluation of 4-chromanones and chalcones, as well as olympicin A and derivatives.4-色满酮和查耳酮以及奥林匹星A及其衍生物的合成、构效关系研究和抗菌评价
J Med Chem. 2014 Oct 23;57(20):8398-420. doi: 10.1021/jm500853v. Epub 2014 Oct 7.
3
Thiazolopyridine ureas as novel antitubercular agents acting through inhibition of DNA Gyrase B.
Arab J Sci Eng. 2022;47(1):75-111. doi: 10.1007/s13369-021-05858-3. Epub 2021 Jun 30.
4
Indole-fused spirochromenes as potential anti-tubercular agents: design, synthesis and in vitro evaluation.吲哚稠合螺色烯作为潜在的抗结核药物:设计、合成和体外评价。
Mol Divers. 2021 Nov;25(4):2137-2148. doi: 10.1007/s11030-020-10108-z. Epub 2020 May 30.
噻唑并嘧啶脲类作为新型抗结核药物,通过抑制 DNA 回旋酶 B 发挥作用。
J Med Chem. 2013 Nov 14;56(21):8834-48. doi: 10.1021/jm401268f. Epub 2013 Oct 18.
4
FtsZ protofilaments use a hinge-opening mechanism for constrictive force generation.FtsZ 原纤维使用铰链打开机制产生收缩力。
Science. 2013 Jul 26;341(6144):392-5. doi: 10.1126/science.1239248.
5
Multidrug-resistant Tuberculosis.耐多药结核病。
Med Clin North Am. 2013 Jul;97(4):553-79, ix-x. doi: 10.1016/j.mcna.2013.03.012.
6
Synthesis and antitubercular activity of amino alcohol fused spirochromone conjugates.氨基醇并色酮类化合物的合成及抗结核活性。
Bioorg Med Chem Lett. 2013 Mar 1;23(5):1416-9. doi: 10.1016/j.bmcl.2012.12.073. Epub 2013 Jan 5.
7
New drugs for the treatment of tuberculosis: needs, challenges, promise, and prospects for the future.新型结核病治疗药物:需求、挑战、前景与展望。
J Infect Dis. 2012 May 15;205 Suppl 2:S241-9. doi: 10.1093/infdis/jis034. Epub 2012 Mar 22.
8
Diversity oriented design of various hydrazides and their in vitro evaluation against Mycobacterium tuberculosis H37Rv strains.各种酰肼的导向多样性设计及其对结核分枝杆菌 H37Rv 株的体外评价。
Bioorg Med Chem Lett. 2011 Aug 15;21(16):4728-31. doi: 10.1016/j.bmcl.2011.06.074. Epub 2011 Jun 23.
9
Antitubercular chromones and flavonoids from Pisonia aculeata.刺桐中的抗结核查耳酮和类黄酮。
J Nat Prod. 2011 May 27;74(5):976-82. doi: 10.1021/np1008575. Epub 2011 May 4.
10
Screening for in vitro antimycobacterial activity and three-dimensional quantitative structure-activity relationship (3D-QSAR) study of 4-(arylamino)coumarin derivatives.筛选体外抗分枝杆菌活性及 4-(芳氨基)香豆素衍生物的三维定量构效关系(3D-QSAR)研究。
Chem Biol Drug Des. 2010 Nov;76(5):412-24. doi: 10.1111/j.1747-0285.2010.00997.x. Epub 2010 Sep 9.